A new study conducted by Quest Diagnostics in collaboration with the University of Alabama has revealed significant gaps in the testing and treatment of sexually transmitted infections (STIs) among pregnant women in the United States. The study, titled Chlamydia and gonorrhea testing in pregnancy: Time to improve adherence and update recommendations, was published in the ‘Journal of Lower Genital Tract Disease’ and…
Needed, a company dedicated to improving perinatal nutrition, has launched Needed Academy, an Instagram-based educational program designed to address the critical need for accurate information on fertility, pregnancy, and postpartum health. Needed Academy is an educational platform specifically created for health practitioners, advocates, and influencer partners associated with Needed. The program responds to the widespread issue of outdated and inaccurate health information…
DiaMedica Therapeutics, a clinical-stage biopharmaceutical company focused on novel treatments for severe ischemic diseases, has announced the initiation of a Phase 2 trial for their preeclampsia treatment, DM199. This announcement came alongside their second quarter 2024 financial results and business update. Preeclampsia (PE) is a serious pregnancy complication characterized by high blood pressure and damage to organ systems, often affecting the kidneys…
Johnson & Johnson has announced significant findings from their Phase 2 UNITY study of nipocalimab for the treatment of pregnant individuals at high risk for early onset severe hemolytic disease of the fetus and newborn (HDFN). The results, published in The New England Journal of Medicine, indicate that nipocalimab can delay or prevent severe fetal anemia and improve birth outcomes. HDFN occurs…
Babylist, a platform trusted by millions of growing families for its wide range of products and services across commerce, media, and health, has announced an expansion of its health offerings. This move aims to provide expecting and new parents with easier and more transparent access to health and wellness products during pregnancy and postpartum. The expansion includes broader coverage with breast pump…
Novocuff, a medical device company focused on improving pregnancy outcomes and reducing preterm births, has successfully closed an oversubscribed $26 million Series A funding round. The round was led by AXA IM Alts, through its Global Healthcare Private Equity Strategy, with a $14 million investment. Significant participation also came from Laerdal Million Lives Fund, along with continued support from existing and new…
French healthtech company Sonio, has introduced Soniopedia, a new cloud-based AI-powered software designed for prenatal ultrasound training. This announcement was made at the World Congress of Fetal Medicine (FMF) in Lisbon. Soniopedia aims to address the training challenges in prenatal ultrasound by simulating cases from the initial ultrasound image to the necessary genetic tests within a single cloud-based platform. Prenatal medicine is…
Menarini Silicon Biosystems (MSB) has presented data at the 2024 Fetal Medicine Foundation (FMF) World Congress in Lisbon, Portugal, demonstrating the accuracy of their cell-based non-invasive prenatal testing (NIPT) technology. The study results indicate that their technology can detect fetal genomic abnormalities through a maternal blood draw with high resolution. MSB offers unique rare cell technologies and solutions that provide clinical researchers…
